other material
confidence high
sentiment positive
materiality 0.55
Apyx Medical publishes 483-patient study showing Renuvion safety after liposuction across multiple body areas
Apyx Medical Corp
- Analysis of 483 patients (1,184 body areas) found no new or increased risks vs. liposuction alone.
- Peer-reviewed publication in Aesthetic Surgery Journal Open Forum; data previously used for FDA 510(k) clearance in 2023.
- CEO states evidence strengthens clinical portfolio for Renuvion; no alternative FDA-cleared therapy exists for the indication.